Trial intelligence / Profile preview

Fluoxetine and Guided Self-Help for Bulimia in Primary Care

NCT00009178Phase 4Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Mar 1998
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of fluoxetine in bulimia nervosa (BN), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 1998; status: completed.

02

Drugs

fluoxetine
03

Conditions

bulimia nervosa (BN)

Beyond the preview

Go deeper on NCT00009178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00009178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call